School of Life Sciences

MRC Genome Damage and Stability Centre

looking for colonies of cells high performance image microscopy preparing for an experiment examining a reaction in a small tube plating out cells into dishes for incubation

The GDSC is a research centre investigating the responses of cells to genome damage and their relationship to cancer and other aspects of human disease.

Medical Research CouncilThe purpose-built laboratories, funded by the Joint Infrastructure Fund (JIF), the Wolfson Foundation and Sussex University, are located adjacent to the School of Life Sciences, and provide a dynamic and collaborative environment for carrying out state-of -the-art research. Much of this research is supported by the Medical Research Council via a Centre Grant and Programme Grants. The Centre currently houses twenty research groups.

Additional funding bodies:

Bioscience for the future logo European Research Council logo Wellcome trust logo Marie Curie logo Ataxia UK logo
Cancer Research UK logo Leukaemia Lymphoma Research logo The Royal Society logo Association for International Cancer Research logo Human Frontier logo

PhD Studentships

 Most studentships in the GDSC are funded by the MRC, BBSRC, EU and Cancer Research UK studentships. These cover registration, running expenses, travel to an international meeting and a stipend. Eligibility for these studentships depends on the criteria set by the funding bodies.


Studentships available from January and May 2014:

For listings of our 2014 PhD studentships please go to:


Job Opportunities:

Research Techncian -

Fixed term for 3 years, full time Salary range:  starting at £27,318 and rising to £30,728 per annum.  It is normal to appoint at the first point of the salary scale. Expected start date June/July 2014 Closing date for applications: 1 May 2014


A Cancer Research UK funded technical position is available for 3 years, in the first instance, in the laboratory of Professor Keith Caldecott, within the Genome Damage and Stability Centre, to identify and validate novel drug targets for anti-cancer treatment. The successful applicant will be highly motivated and will join a well funded and productive research group focused on identifying and characterising molecular mechanisms that govern genome stability in response to DNA damage. The position will be part of a multidisciplinary research effort at the University of Sussex and will work closely with the Translational Drug Discovery Group.

Informal enquiries and requests for additional project details can be directed to Professor Keith Caldecott,

Ref 556 Further particulars including person specification [PDF 123.13KB]

For further details of this position please go to: